Upstream Bio (UPB) Current Leases (2023 - 2026)

Upstream Bio (UPB) posted quarterly Current Leases of $724000.0 for Q1 2026, up 2.26% year-over-year from $708000.0 in Q1 2025, and up 0.56% quarter-over-quarter from $720000.0 in Q4 2025.

Upstream Bio (UPB) Current Leases (2023 - 2026) Analysis & Trends

Upstream Bio's Current Leases history runs 4 years deep, the most recent figure standing at $724000.0 for Q1 2026.

  • In Q1 2026, Current Leases rose 2.26% year-over-year to $724000.0; the TTM figure through Mar 2026 stood at $724000.0 (up 2.26% YoY), while the FY2025 annual figure was $720000.0, up 2.27% from the prior year.
  • Current Leases for Q1 2026 stood at $724000.0, up from $720000.0 in the prior quarter.
  • The five-year high for Current Leases was $724000.0 in Q1 2026, with the low at $45000.0 in Q4 2023.
  • The 4-year median for Current Leases is $710000.0 (2025), against an average of $625875.0.
  • The sharpest annual moves came in 2024 and 2026: Current Leases soared 1464.44% in 2024, then grew 2.26% in 2026.
  • Upstream Bio's Current Leases stood at $45000.0 in 2023, then jumped by 1464.44% to $704000.0 in 2024, then climbed by 2.27% to $720000.0 in 2025, then grew by 0.56% to $724000.0 in 2026.
  • Business Quant data shows UPB's Current Leases at $724000.0 in Q1 2026, $720000.0 in Q4 2025, and $716000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 11.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 16.75 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 21.95 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2.24 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 45.93 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 6.27 Mn
10 Upstream Bio 387.23 Mn 387.23 Mn -3.29 Mn 728,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 728,000.00
Mar 31, 2026 724,000.00
Dec 31, 2025 720,000.00
Sep 30, 2025 716,000.00
Jun 30, 2025 712,000.00
Mar 31, 2025 708,000.00
Dec 31, 2024 704,000.00
Sep 30, 2024 678,000.00
Dec 31, 2023 45,000.00